APA (7th ed.) Citation

Voskaridou, E., Ntanasis-Stathopoulos, I., Christoulas, D., Sonnleitner, L., Papaefstathiou, A., Dimopoulou, M., . . . Terpos, E. (2019). Denosumab effects on serum levels of the bone morphogenetic proteins antagonist noggin in patients with transfusion-dependent thalassemia and osteoporosis. Hematology, 24(1), 318. https://doi.org/10.1080/16078454.2019.1570617

Chicago Style (17th ed.) Citation

Voskaridou, Ersi, et al. "Denosumab Effects on Serum Levels of the Bone Morphogenetic Proteins Antagonist Noggin in Patients with Transfusion-dependent Thalassemia and Osteoporosis." Hematology 24, no. 1 (2019): 318. https://doi.org/10.1080/16078454.2019.1570617.

MLA (9th ed.) Citation

Voskaridou, Ersi, et al. "Denosumab Effects on Serum Levels of the Bone Morphogenetic Proteins Antagonist Noggin in Patients with Transfusion-dependent Thalassemia and Osteoporosis." Hematology, vol. 24, no. 1, 2019, p. 318, https://doi.org/10.1080/16078454.2019.1570617.